Literature DB >> 21492065

Human telomerase reverse transcriptase regulates cyclin D1 and G1/S phase transition in laryngeal squamous carcinoma.

Jun Li1, Xinsheng Huang, Xiaofeng Xie, Jianzhong Wang, Maoli Duan.   

Abstract

CONCLUSION: Down-regulating human telomerase reverse transcriptase (hTERT) expression will significantly suppress the cell viability of laryngeal squamous cell carcinoma Hep-2, which was mainly due to the inhibition of cyclin D1 and thus G1/S phase transition.
OBJECTIVE: Small-interfering RNA (siRNA) targeting hTERT can arrest the cell cycle of cancer cells, as well as inhibit telomerase activity and cell viability. However, the precise mechanisms still remain unclear. Here, we investigate the regulatory role of hTERT in cyclin D1 in laryngeal squamous carcinoma.
METHODS: Short hairpin RNAs (shRNAs) specifically targeting hTERT were constructed and expressed in Hep-2 cells. Cell proliferation was measured by CCK-8 assay. Expression of hTERT, cyclin D1, cyclin E, c-myc, and GAPDH was detected by RT-PCR and Western blot; cyclin D1 and hTERT proteins in laryngeal squamous carcinoma tissue microarray were analyzed by quantum dots immunofluorescence.
RESULTS: hTERT silence by shRNAs decreased the proliferation of Hep-2 cells by 76.8% at day 4 (96 h). Furthermore, transfection with hTERT shRNA for 48 h also significantly reduced expression of hTERT, cyclin D1, and c-Myc, but not cyclin E. Quantum dots immunofluorescence analysis of 36 laryngeal squamous carcinoma tissue samples found that hTERT expression was highly correlated with cyclin D1 expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21492065     DOI: 10.3109/00016489.2011.557393

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

Review 1.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

2.  Expression of cyclin D1 and cyclin E in urothelial bladder carcinoma detected in tissue chips using a quantum dot immunofluorescence technique.

Authors:  Guang Shan; Tian Tang
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

Review 3.  Current Insights to Regulation and Role of Telomerase in Human Diseases.

Authors:  Mert Burak Ozturk; Yinghui Li; Vinay Tergaonkar
Journal:  Antioxidants (Basel)       Date:  2017-02-28

Review 4.  Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?

Authors:  Amir Barzegar Behrooz; Amir Syahir
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

5.  Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity.

Authors:  Zhaowen Zhu; Huy Tran; Meleah M Mathahs; Brian D Fink; John A Albert; Thomas O Moninger; Jeffery L Meier; Ming Li; Warren N Schmidt
Journal:  Pharmacol Res Perspect       Date:  2021-12

6.  Metabolic Reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT.

Authors:  Hiromi Onizuka; Kenta Masui; Kosaku Amano; Takakazu Kawamata; Tomoko Yamamoto; Yoji Nagashima; Noriyuki Shibata
Journal:  Acta Histochem Cytochem       Date:  2021-06-23       Impact factor: 1.938

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.